Neurosense Therapeuti -CW23NRSNWPreferred / convertible
13F holders, Q3 2024 (September 30)4holders
0new positions
0sold out
1famous investor
$0.15avg. 13F price*
At the end of Q3 2024, 4 institutions reported holding Neurosense Therapeuti -CW23 (NRSNW) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holders were Clear Street LLC ($10K), Citadel Advisors ($4K) and Warberg Asset Management LLC ($3K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Neurosense Therapeuti -CW23
- CUSIP
- M74240116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 6,487 shares bought and 16,400 shares sold, net −9,913 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Clear Street LLC | — | Add +10.9% | 65,759 | $10K |
| Citadel Advisors | — | Reduce -14.2% | 25,274 | $4K |
| Warberg Asset Management LLC | — | Reduce -36.9% | 20,201 | $3K |
| UBS Group AG | — | Reduce -66.9% | 200 | $28 |
"% of holder's portfolio" is NRSNW's weight in each manager's 13F, not the share of Neurosense Therapeuti -CW23 the manager owns.